| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 243.08B | 240.34B | 229.71B | 212.04B | 172.74B | 150.42B |
| Gross Profit | 100.13B | 95.57B | 88.21B | 78.51B | 69.45B | 58.63B |
| EBITDA | 23.82B | 23.95B | 20.60B | 15.80B | 12.74B | 6.72B |
| Net Income | 14.99B | 15.24B | 14.31B | 9.91B | 7.72B | 3.75B |
Balance Sheet | ||||||
| Total Assets | 214.91B | 218.48B | 206.15B | 197.52B | 166.36B | 157.14B |
| Cash, Cash Equivalents and Short-Term Investments | 35.99B | 32.40B | 31.96B | 23.84B | 24.43B | 22.64B |
| Total Debt | 12.99B | 16.60B | 13.40B | 24.81B | 11.21B | 18.07B |
| Total Liabilities | 57.82B | 61.35B | 64.08B | 73.24B | 53.89B | 52.96B |
| Stockholders Equity | 156.30B | 156.35B | 141.45B | 123.74B | 111.98B | 103.78B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.73B | 20.11B | -12.43B | 10.14B | 7.41B |
| Operating Cash Flow | 0.00 | 7.01B | 21.41B | -8.05B | 12.04B | 8.78B |
| Investing Cash Flow | 0.00 | -3.51B | 131.00M | -4.45B | -2.18B | -841.00M |
| Financing Cash Flow | 0.00 | -4.01B | -14.01B | 11.01B | -8.77B | -2.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥277.85B | 11.87 | 10.61% | 1.81% | 5.29% | 16.34% | |
65 Neutral | ¥973.36B | 17.87 | 49.14% | 2.82% | 6.80% | 0.62% | |
64 Neutral | ¥77.66B | 10.29 | ― | 2.11% | 6.04% | 93.19% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥44.65B | 15.79 | ― | 3.31% | 0.88% | -138.66% | |
43 Neutral | ¥10.45B | 19.13 | ― | 3.08% | 3.31% | -94.69% | |
41 Neutral | ¥1.68T | -12.21 | -21.14% | ― | 11.45% | 42.34% |